US2017136148A1PendingUtilityA1

Auto-grafting

49
Assignee: DERMAGENESIS LLCPriority: Nov 20, 2013Filed: Nov 30, 2016Published: May 18, 2017
Est. expiryNov 20, 2033(~7.4 yrs left)· nominal 20-yr term from priority
A61F 2230/0017C12N 5/0625A61L 27/24C12N 5/0698A61L 2430/34A61L 27/227A61L 27/3895A61L 2300/414C12N 2502/094C12M 41/48A61L 2300/412A61F 2240/002B33Y 10/00A61L 27/3604A61F 2210/0004B29K 2089/00A61L 27/60A61L 2300/64C12N 2513/00B33Y 80/00B29L 2031/7532A61L 27/26A61F 2230/0063C12M 21/08C12N 2533/54A61F 2/105A61L 27/3813A61L 27/3691B33Y 30/00A61L 27/3886B33Y 50/00C12N 2502/13B33Y 50/02A61L 27/362B29C 67/0085B29C 67/0055B29C 67/0088B29C 64/106A61K 35/36
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An apparatus and method for the production of substitute skin that advantageously reduces the amount of donor dermal cells needed from non-wound areas of a patient having a wound to be auto-grafted is reduced by using all of the harvested skin cells. A 3D printer is used to construct a wound graft product from the harvested skin cells without wasting any of the harvested skin cells. In a case of an irregularly shaped wound, wastage of harvested skin associated with trimming is avoided.

Claims

exact text as granted — not AI-modified
1 - 48 . (canceled) 
     
     
         49 . An auto-grafting method for treating a wound of a patient, comprising:
 harvesting a quantity of skin cells from a patient;   auto-grafting onto the wound of the patient the quantity of harvested skin cells, with the quantity of autografted harvested skin cells being substantially equal to the quantity of harvested skin cells.   
     
     
         50 . The auto-grafting method of  claim 49 , wherein the auto-grafting step comprises auto-grafting a three-dimensional irregularly-shaped skin graft product. 
     
     
         51 . The auto-grafting method of  claim 49 , further comprising constructing, via operation of a three-dimensional printer, a skin graft product comprising the quantity of harvested skin cells. 
     
     
         52 . The method of claim  21 , further comprising printing insulin into the skin graft product being constructed. 
     
     
         53 . The method of claim  21 , further comprising printing or spraying amniotic membrane into the skin graft product being constructed.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.